FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

48 results

actimmune
(Interferon gamma-1b)
Horizon Therapeutics USA, Inc.
Usage: ACTIMMUNE is indicated for reducing serious infections in patients with Chronic Granulomatous Disease (CGD) and for delaying disease progression in severe, malignant osteopetrosis (SMO).
alrex
(loteprednol etabonate)
Bausch & Lomb Incorporated
Usage: ALREX ophthalmic suspension is indicated for the temporary relief of signs and symptoms associated with seasonal allergic conjunctivitis.
anoro ellipta
(umeclidinium bromide and vilanterol trifenatate)
GlaxoSmithKline LLC
Usage: ANORO ELLIPTA is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is not intended for the relief of acute bronchospasm or asthma treatment, and its safety and effectiveness in asthma have not been established.
asceniv
(HUMAN IMMUNOGLOBULIN G)
ADMA Biologics, Inc.
Usage: ASCENIV is indicated for the treatment of primary humoral immunodeficiency (PI) in adults and adolescents (12-17 years), including conditions such as congenital agammaglobulinemia, common variable immunodeficiency, X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.
auvi-q
(epinephrine)
kaleo, Inc
Usage: AUVI-Q® is indicated for the emergency treatment of Type I allergic reactions, including anaphylaxis due to insect stings, food, medications, and other allergens. It is intended for immediate self-administration in individuals at risk for anaphylaxis and is not a substitute for medical care.
bepreve
(bepotastine besilate)
Bausch & Lomb Incorporated
Usage: BEPREVE® (bepotastine besilate ophthalmic solution) 1.5% is indicated for treating itching linked to allergic conjunctivitis symptoms.
bivigam
(Immune Globulin Intravenous (Human) 10%)
ADMA Biologics, Inc.
Usage: BIVIGAM is indicated for treating primary humoral immunodeficiency (PI) in adults and children aged 2 years and older. It addresses conditions such as common variable immunodeficiency, X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.
cinqair
(Reslizumab)
Teva Respiratory, LLC
Usage: CINQAIR® is indicated as an add-on maintenance treatment for adults (18+) with severe asthma exhibiting an eosinophilic phenotype. It is not intended for other eosinophilic conditions or for acute bronchospasm relief or status asthmaticus.
complera
(emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate)
Gilead Sciences, Inc.
Usage: COMPLERA® is indicated for treating HIV-1 in adults and children (≥35 kg) as initial therapy for those with no treatment history and HIV-1 RNA ≤100,000 copies/mL, or to replace a stable regimen in virologically suppressed patients. Limitations include risk of virologic failure in those with higher baseline HIV-1 RNA.
delstrigo
(doravirine, lamivudine, and tenofovir disoproxil fumarate)
Merck Sharp & Dohme LLC
Usage: DELSTRIGO® is indicated for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg, either as a complete regimen for those with no prior antiretroviral treatment or to replace the current regimen in patients who are virologically suppressed with no history of treatment failure.

Immunology & Inflammation drugs

actimmune

alrex

anoro ellipta

asceniv

auvi-q

bepreve

bivigam

cinqair

complera

delstrigo